Cargando…

Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study

BACKGROUND: The psychosocial development of pediatric HIV patients has not been extensively evaluated. The study objectives were to evaluate whether emotional and social functions are differentially associated with HIV-related complications. METHODS: A matched case-control study design was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomaidis, Loretta, Bertou, Georgia, Critselis, Elena, Spoulou, Vassiliki, Kafetzis, Dimitrios A, Theodoridou, Maria
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022796/
https://www.ncbi.nlm.nih.gov/pubmed/21184692
http://dx.doi.org/10.1186/1471-2431-10-99
_version_ 1782196582272204800
author Thomaidis, Loretta
Bertou, Georgia
Critselis, Elena
Spoulou, Vassiliki
Kafetzis, Dimitrios A
Theodoridou, Maria
author_facet Thomaidis, Loretta
Bertou, Georgia
Critselis, Elena
Spoulou, Vassiliki
Kafetzis, Dimitrios A
Theodoridou, Maria
author_sort Thomaidis, Loretta
collection PubMed
description BACKGROUND: The psychosocial development of pediatric HIV patients has not been extensively evaluated. The study objectives were to evaluate whether emotional and social functions are differentially associated with HIV-related complications. METHODS: A matched case-control study design was conducted. The case group (n = 20) consisted of vertically infected children with HIV (aged 3-18 years) receiving HAART in Greece. Each case was matched with two randomly selected healthy controls from a school-based population. CNS imaging and clinical findings were used to identify patients with HIV-related neuroimaging abnormalities. The Wechsler Intelligence Scale III and Griffiths Mental Abilities Scales were applied to assess cognitive abilities. The age specific Strengths and Difficulties Questionnaire was used to evaluate emotional adjustment and social skills. The Fisher's exact test, student's t-test, and Wilcoxon rank sum test were used to compare categorical, continuous, and ordinal scores, respectively, of the above scales between groups. RESULTS: HIV patients without neuroimaging abnormalities did not differ from patients with neuroimaging abnormalities with respect to either age at HAART initiation (p = 0.306) or months of HAART treatment (p = 0.964). While HIV patients without neuroimaging abnormalities had similar cognitive development with their healthy peers, patients with neuroimaging abnormalities had lower mean General (p = 0.027) and Practical (p = 0.042) Intelligence Quotient scores. HIV patients without neuroimaging abnormalities had an increased likelihood of both Abnormal Emotional Symptoms (p = 0.047) and Hyperactivity scores (p = 0.0009). In contrast, HIV patients with neuroimaging abnormalities had an increased likelihood of presenting with Abnormal Peer Problems (p = 0.033). CONCLUSIONS: HIV patients without neuroimaging abnormalities are more likely to experience maladjustment with respect to their emotional and activity spheres, while HIV patients with neuroimaging abnormalities are more likely to present with compromised social skills. Due to the limited sample size and age distribution of the study population, further studies should investigate the psychosocial development of pediatric HIV patients following the disclosure of their condition.
format Text
id pubmed-3022796
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30227962011-01-19 Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study Thomaidis, Loretta Bertou, Georgia Critselis, Elena Spoulou, Vassiliki Kafetzis, Dimitrios A Theodoridou, Maria BMC Pediatr Research Article BACKGROUND: The psychosocial development of pediatric HIV patients has not been extensively evaluated. The study objectives were to evaluate whether emotional and social functions are differentially associated with HIV-related complications. METHODS: A matched case-control study design was conducted. The case group (n = 20) consisted of vertically infected children with HIV (aged 3-18 years) receiving HAART in Greece. Each case was matched with two randomly selected healthy controls from a school-based population. CNS imaging and clinical findings were used to identify patients with HIV-related neuroimaging abnormalities. The Wechsler Intelligence Scale III and Griffiths Mental Abilities Scales were applied to assess cognitive abilities. The age specific Strengths and Difficulties Questionnaire was used to evaluate emotional adjustment and social skills. The Fisher's exact test, student's t-test, and Wilcoxon rank sum test were used to compare categorical, continuous, and ordinal scores, respectively, of the above scales between groups. RESULTS: HIV patients without neuroimaging abnormalities did not differ from patients with neuroimaging abnormalities with respect to either age at HAART initiation (p = 0.306) or months of HAART treatment (p = 0.964). While HIV patients without neuroimaging abnormalities had similar cognitive development with their healthy peers, patients with neuroimaging abnormalities had lower mean General (p = 0.027) and Practical (p = 0.042) Intelligence Quotient scores. HIV patients without neuroimaging abnormalities had an increased likelihood of both Abnormal Emotional Symptoms (p = 0.047) and Hyperactivity scores (p = 0.0009). In contrast, HIV patients with neuroimaging abnormalities had an increased likelihood of presenting with Abnormal Peer Problems (p = 0.033). CONCLUSIONS: HIV patients without neuroimaging abnormalities are more likely to experience maladjustment with respect to their emotional and activity spheres, while HIV patients with neuroimaging abnormalities are more likely to present with compromised social skills. Due to the limited sample size and age distribution of the study population, further studies should investigate the psychosocial development of pediatric HIV patients following the disclosure of their condition. BioMed Central 2010-12-27 /pmc/articles/PMC3022796/ /pubmed/21184692 http://dx.doi.org/10.1186/1471-2431-10-99 Text en Copyright ©2010 Thomaidis et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Thomaidis, Loretta
Bertou, Georgia
Critselis, Elena
Spoulou, Vassiliki
Kafetzis, Dimitrios A
Theodoridou, Maria
Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study
title Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study
title_full Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study
title_fullStr Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study
title_full_unstemmed Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study
title_short Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study
title_sort cognitive and psychosocial development of hiv pediatric patients receiving highly active anti-retroviral therapy: a case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022796/
https://www.ncbi.nlm.nih.gov/pubmed/21184692
http://dx.doi.org/10.1186/1471-2431-10-99
work_keys_str_mv AT thomaidisloretta cognitiveandpsychosocialdevelopmentofhivpediatricpatientsreceivinghighlyactiveantiretroviraltherapyacasecontrolstudy
AT bertougeorgia cognitiveandpsychosocialdevelopmentofhivpediatricpatientsreceivinghighlyactiveantiretroviraltherapyacasecontrolstudy
AT critseliselena cognitiveandpsychosocialdevelopmentofhivpediatricpatientsreceivinghighlyactiveantiretroviraltherapyacasecontrolstudy
AT spoulouvassiliki cognitiveandpsychosocialdevelopmentofhivpediatricpatientsreceivinghighlyactiveantiretroviraltherapyacasecontrolstudy
AT kafetzisdimitriosa cognitiveandpsychosocialdevelopmentofhivpediatricpatientsreceivinghighlyactiveantiretroviraltherapyacasecontrolstudy
AT theodoridoumaria cognitiveandpsychosocialdevelopmentofhivpediatricpatientsreceivinghighlyactiveantiretroviraltherapyacasecontrolstudy